Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More: Gilead’s Veklury becomes first FDA-approved drug for treating COVID-19 »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First… »
The turnover rate for hospital CEOs dipped slightly in 2019 to 17%, after remaining at 18% for the last five years, according to a recent report from the American College of Healthcare Executives. Since 2012, the turnover rate was 17% or higher, which is the longest period of time the rate has been so high… Read More: Hospital CEO turnover rate dipped in 2019 for the first… »
Dive Brief: The healthcare sector added 358,000 jobs throughout the last two weeks of May and the first two weeks of June, according to the U.S. Bureau of Labor Statistics monthly jobs report. Similar to last month’s report, dentists and physician’s offices saw notable gains: 190,000 and 80,000 jobs added, respectively. Hospitals added about 7,000 jobs,… Read More: Healthcare sector added 358K jobs, hospitals had first gains in… »